Discover the future of Biopharma Innovation

We are excited to unveil the agenda for the Alcura Summit 2025...

Agenda highlights:

• 9:00 am – 9:30 am: Arrival of attendees, welcome coffee.
• 9:30 am – 9:45 am: Welcome and Alcura Opening. Speaker: Remedios Parra, VP & Managing Director, Cencora – Spain.
• 9:45am – 10:30 am: Keynote session "Clinical trials: One size does not fit all" by Mary Stutts, CEO of Healthcare Businesswomen's Association (HBA).
  
  This session explores the need for clinical trial approaches that embrace patient diversity, disease complexity, and evolving research methodologies. It advocates for inclusive designs that ensure equitable representation and more impactful outcomes.
• 10:30 am – 11:30 am: IQVIA study presentation "Innovators in action: The transformative power of emerging biopharma companies" by Murray Aitken, Executive Director, IQVIA Institute for Human Data Science. This research highlights the pivotal role of EBPs in drug development and commercialization, covering:
  • EBP contributions by clinical phase, therapeutic area, and region.
  • Revenue comparison between EBP-originated and traditional therapies.
  • M&A trends and future collaboration forecasts.
  • Impact of patent expirations and sales outlook for CGT and mRNA therapies.
  • Identification of potential blockbuster therapies and external sales drivers.
  • EMA vs. FDA approval timelines and regional market access disruptors.
  • China's influence on global trials, regulatory pathways, and real-world data use.
• 11:30 am – 12:15 pm: Panel discussion: Disruptive biotech. Moderated by: Imogen Poliszczuk, Commercial Divisional Director, Clinical Trials. Join industry leaders to discuss:
  • Innovation and discoveries from EBPs
  • Next-generation therapies
  • Collaboration for scalable success
  Panelists:
  • Andrea Romero, CEO and Co-founder, Konexio Biotech
  • Ramón Mel, CEO, SOLTI Cancer Research
  • Stefanos Theoharis, CEO, OneChain Immunotherapies
  • Alexandre Marfany, CEO and Chairman, CELLAB CDMO
• 12:15 pm-12:45 pm: Coffee break.
• 12:45 pm – 1:30 pm: Commercialization case study. Discussion with Jedd Comiskey,  SVP – Head of Europe at Outlook Therapeutics and Guillaume Nebout, VP International Commercial Services at Cencora.
  
  Learn about the role of Cencora in the commercialization process, including how Cencora supports biotechs in their transition from the clinical stage to commercialization through integrated services.
• 1:30 pm – 2:15 pm: Clinical trials case study. Discussion with Manuel Sanz, COO and founder of Oncomatryx Biopharma. Moderated by: Josep Oriol Nicolás, managing director at Alcura.
  
  Oncomatryx will delve into their innovative clinical strategies, address key regulatory challenges, share their vision for clinical development, discuss their investment approach, and highlight the value of their collaboration with Alcura.
• 2:15 pm - 2:30 pm: Corporate closing. Speaker: Javier Casas, VP of Clinical Trials and Regional Managing Director for Spain, Norway, and the Netherlands at Cencora.
• 2:30 pm – 3:30 pm: Networking lunch connect with peers and industry leaders while discussing insights from the day.

Why Attend?
The Alcura summit 2025 offers a unique platform to engage with top experts and gain valuable perspectives on the evolving biotech landscape. Attendees will have the chance to:

• Learn from industry leaders about innovative approaches to clinical trials and commercialization.
• Network with peers and potential collaborators to forge impactful connections.
• Participate in discussions that will shape the future of drug development and healthcare.

Note: Agenda timings are subject to change.